Micronoma in the News
Micronoma Breaks Through With Microbiome-BIOTECH: FDA Designation a ‘Milestone’
Feb 8, 2023
Micronoma’s microbiome platform is breaking into its next phase with validation from the U.S. Food and Drug Administration.
FDA Grants Novel Liquid Biopsy Assay Breakthrough Device Designation to Detect Lung Cancer
Jan 30, 2023
The FDA has granted breakthrough device designation to the novel, microbiome-driven, liquid biopsy assay OncobiotaLUNG for the detection of lung carcinomas, according to a press release from developer Micronoma.1
Micronoma Gets Breakthrough Device Nod for Early Lung Cancer Test
Jan 30, 2023
The FDA has granted Breakthrough Device status to Micronoma’s OncobiotaLUNG microbiome-driven blood assay for early lung cancer detection.
FDA Grants Breakthrough Device Designation to OncobiotaLUNG Assay for Lung Cancer Detection
Jan 30, 2023
The FDA has granted the OncobiotaLUNG assay a breakthrough device designation for the early detection of lung cancer.
Micronoma Receives FDA Breakthrough Device Designation for OncobiotaLUNG, A Novel Liquid Biopsy Assay for Lung Carcinoma Detection
Jan 30, 2023
Micronoma, the first biotech company offering early cancer detection with a microbiome-driven liquid biopsy platform, announced today that its OncobiotaLUNG assay received the Breakthrough Device Designation from the Food and Drug Administration (FDA).
Highs And Lows In The Under 30 World: From A Cancer Screening Breakthrough To A JP Morgan Lawsuit
Jan 30, 2023
Lung cancer is currently the deadliest cancer in the U.S., and unfortunately, even a proper screening for the disease comes with its risks. That’s why Gregory Sepich-Poore, cofounder of Micronoma and an honoree of the Forbes Under 30 2023 Healthcare list, and his team have set out to revolutionize how doctors diagnose lung cancer.
Forbes 30 Under 30 North America 2023 Healthcare
Nov 30, 2022
Forbes has named Micronoma CAO and Co-founder Gregory Sepich-Poore one of its 30 Under 30 in Healthcare for 2023.
Bacteria in tumors may promote cancer
Nov 16, 2022
Microbial interlopers may set off chain reaction that can suppress immune system and lead to metastasis.
Translating the Microbiome
Oct 21, 2022
A flurry of microbiome research over the past two decades has led to many insights about the link between the microbes and health, but now the race to the clinic is on.
How Fungi May Open Up New Doors for Cancer Diagnosis, Treatment
Oct 3, 2022
Experts say fungi can be found in a variety of places in the human body as well as in cancer tumors.
Tumor Associated Fungal Signatures May Offer Diagnostic Insights
Oct 3, 2022
First-ever mycobiome atlas describes associations between cancers and fungi
Oct 3, 2022
An international team of scientists, co-led by researchers at the University of California San Diego School of Medicine, has created the first pan-cancer mycobiome atlas — a survey of 35 types of cancer and their associated fungi.
Fungal DNA, Cells Found in Human Tumors
Sep 30, 2022
Fungal DNA is present in various types of cancer, according to two studies published yesterday (September 29) in Cell.
Map of Links between Cancers and Fungi Created
A research team led by the University of California San Diego and the Weizmann Institute of Science in Israel has created an atlas of fungi linked to a range of 35 different cancers for the first time.
A New Approach to Spotting Tumors: Look for Their Microbes
Sep 29, 2022
New research is revealing that cancer is rife with bacteria and fungi – a rich ecosystem that scientists call the tumor microbiome.
Leading-Edge Approaches To Early Cancer Detection
Sep 22, 2022
Emerging approaches to the early detection of cancer, based on metabolic profiling and microbiome- and exosome-driven liquid biopsies, were highlighted during the recent Next Generation Dx Summit held in Washington, D.C.
Special Report: Life Science, Merging the Biological With the Computational
May 25, 2022
When scientists began mapping of the human genome, the discoveries in our DNA unleashed an era of biology that advanced breakthroughs in diagnostics and biomedicine beyond what was imaginable when the work began.
These innovative projects are changing the health industry
May 3, 2022
The health category of Fast Company’s World Changing Ideas Awards honors medical innovations that save lives, extend longevity, or increase access to care.
Microbiome Therapeutics Try a Lighter Touch
Apr 4, 2022
The revelation that our commensal bacteria play important roles in health and disease has turned the microbiome into one of the most active frontiers of biomedicine.
Could Cancer’s Microbiome Help Diagnose and Treat the Disease?
Mar 14, 2022
As a postdoc at the Broad Institute of MIT and Harvard in 2008, cancer biologist Ravid Straussman worked on a collaborative effort to screen normal cells for their influence on cancer cells’ responses to various anticancer therapies.
Precision medicine through the cancer microbiome
Mar 2, 2022
With its Oncobiota platform, Micronoma is pioneering the analysis of the cancer microbiome for early cancer detection and creating tools for personalized cancer treatment.
Micronoma, University of New South Wales to Develop Liver Cancer Dx Using $4M Grant
Jul 20, 2021
Microbial cancer detection firm Micronoma said Tuesday that it is collaborating with University of New South Wales.
Human Blood Harbors Cell-Free Microbial DNA
Jul 14, 2021
After controlling for high levels of bacterial contamination in their lab and reagents, researchers detect microbial genetic material in plasma samples from healthy people and cancer patients.
Micronoma Closes $3.5M Convertible Debt Financing Round
Feb 22, 2021
Micronoma, a San Diego, Calif.-based cancer detection biotech company that utilizes signals from the tumor-related microbiome to diagnose cancer at an early stage with liquid biopsy technology, closed a $3.5m convertible debt financing round.
Microbiome-based diagnostics and biomarkers
Feb 2, 2021
Microbiome-based diagnostics and biomarkers: Changing the paradigm in microbiology and medicine.
Micronoma Establishes Scientific Advisory Board
Dec 14, 2020
Micronoma, the first cancer detection biotech company that uses signals from the tumor-related microbiome to diagnose cancer at an early stage with minimally-invasive liquid biopsy technology, today announced the formation of its scientific advisory board (SAB).
Micronoma Appoints Magda Marquet to Chairman of the Board
Oct 07 , 2020
San Diego-based Micronoma, a startup using microbiome analysis for early cancer detection, has appointed Magda Marquet as chairman of the firm’s board.
Prime Time for the Microbiome
Sep 28, 2020
Microbiomics is taking a sharp turn. Until now, the field was limited to fecal transplants from healthy patients to those with gut conditions.
S.D. biotech lab with ties to UC San Diego works to develop faster cancer detectionMicronoma Establishes Scientific Advisory Board
Sept 04, 2020
A San Diego-based biotech firm that has co-founders from UC San Diego is working to develop and commercialize a minimally invasive method for early cancer detection and recently closed a $3 million seed financing round to further its results.
Micronoma Launches with $3 Million Seed Funding
Aug 19 , 2020
Micronoma, an early cancer-detection biotech that seeks to develop and commercialize a minimally invasive, microbiome-based method, announced today that it has closed a $3 million seed financing round led by microbiome-focused investor, SymBiosis, LLC.
Start-Up Developing Microbial Cancer Detection Tests
Aug 13, 2020
A new company, spun off from university biomedical engineering labs, is creating early cancer diagnostics by analyzing microbial genetics in simple blood samples.
Micronoma Finds $3M For Early Cancer Detection
Aug 13, 2020
San Diego-based Micronoma, a startup working on early cancer detection, announced this morning that it has raised $3M in a seed financing round.
Microbial Signatures in Blood Are Associated with Various Cancers
Jul 13, 2020
A study suggests the potential for a noninvasive diagnostic that could detect tumors early and differentiate between disease types.
Microbiome analyses of blood and tissues suggest cancer diagnostic approach
Mar 20, 2020
The story behind this paper begins with the loss of my grandmother to pancreatic cancer and the relentless pursuit to understand her disease.
Microbial DNA in Patient Blood May be Tell-Tale Sign of Cancer
Mar 11, 2020
From a simple blood draw, microbial DNA may reveal who has cancer and which type, even at early stages
Website Terms of Use, Privacy Policy, and Licenses
Micronoma, INC., CLIA #05D2253538
Oncobiota™ LDT is under development and is currently not available for commercial use in any jurisdiction. Once available under CLIA license, Oncobiota™ will be available in the United States by prescription only.
Contact Us
If you have questions or would like to learn more, please email us at info@micronoma.com or learn about joining our team at Careers.
Micronoma
6342 Ferris Square
San Diego, CA 92121